Antidepressant Effects of TrkB Ligands on Depression-Like Behavior and Dendritic Changes in Mice After Inflammation
Open accessThe DOI matches its Crossref record; 72 of the 72 references it cites were found in a registry or an index.
Abstract
BACKGROUND: Brain-derived neurotrophic factor (BDNF) and its receptor, tropomyosin-related kinase B (TrkB), signaling represent potential therapeutic targets for major depressive disorder. The purpose of this study is to examine whether TrkB ligands show antidepressant effects in an inflammation-induced model of depression. METHODS: In this study, we examined the effects of TrkB agonist 7,8-dihydroxyflavone (7,8-DHF) and TrkB antagonist ANA-12 on depression-like behavior and morphological changes in mice previously exposed to lipopolysaccharide (LPS). Protein levels of BDNF, phospho-TrkB (p-TrkB), and TrkB in the brain regions were also examined. RESULTS: LPS caused a reduction of BDNF in the CA3 and dentate gyrus (DG) of the hippocampus and prefrontal cortex (PFC), whereas LPS increased BDNF in the nucleus accumbens (NAc). Dexamethason suppression tests showed hyperactivity of the hypothalamic-pituitary-adrenal axis in LPS-treated mice. Intraperitoneal (i.p.) administration of 7,8-DHF showed antidepressant effects on LPS-induced depression-like behavior, and i.p. pretreatment with ANA-12 blocked its antidepressant effects. Surprisingly, ANA-12 alone showed antidepressant-like effects on LPS-induced depression-like behavior. Furthermore, bilateral infusion of ANA-12 into the NAc showed antidepressant effects. Moreover, LPS caused a reduction of spine density in the CA3, DG, and PFC, whereas LPS increased spine density in the NAc. Interestingly, 7,8-DHF significantly attenuated LPS-induced reduction of p-TrkB and spine densities in the CA3, DG, and PFC, whereas ANA-12 significantly attenuated LPS-induced increases of p-TrkB and spine density in the NAc. CONCLUSIONS: The results suggest that LPS-induced inflammation may cause depression-like behavior by altering BDNF and spine density in the CA3, DG, PFC, and NAc, which may be involved in the antidepressant effects of 7,8-DHF and ANA-12, respectively.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures





Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Blockade of NLRP3 reverses stress-induced increases in IL-1β in the peripheral blood and brain, while also abrogating depressive-like behaviour in mice45.”
From The role of inflammation in depression: from evolutionary imperative to modern treatment target (2016) · cites this paper as [45]
Experimental — accuracy not yet measuredThe check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“studies in laboratory animals indicate that chronic mild-stress activates the NOD-, LRR- and pyrin domain-containing protein 3 (NLRP3) inflammasome, which is well-known to respond to DAMPs44,45.”
From The role of inflammation in depression: from evolutionary imperative to modern treatment target (2016) · cites this paper as [45]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The Mouse Brain in Stereotaxic Coordinates
Paxinos, G. (2001) · Cited by 13,416
Molecular Mechanisms of Depression: Perspectives on New Treatment Strategies
Lang, U. E., & Borgwardt, S. (2013) · Cellular Physiology and Biochemistry · doi:10.1159/000350094 · Cited by 8,475
From inflammation to sickness and depression: when the immune system subjugates the brain
Dantzer, R., O'Connor, J. C., Freund, G. G., Johnson, R. W., & Kelley, K. W. (2008) · Nature Reviews Neuroscience · doi:10.1038/nrn2297 · Cited by 7,395 · cited 4×
“Peripheral administration of LPS induces sickness behavior that peaks after two to six hours, then gradually wanes (Dantzer et al., 2008).”
BackgroundInfluentialPhysiology and neurobiology of stress and adaptation: central role of the brain
McEwen, B. S. (2007) · Physiological Reviews · doi:10.1152/physrev.00041.2006 · Cited by 5,429 · cited 2×
“Changes in dendritic length and spine density in the hippocampus and PFC are thought to contribute to the neurobiology of MDD, and antidepressant treatment is mediated, in part, by blocking or reversing these changes (McEwen, 2007; Duman and Aghajanian, 2012).”
BackgroundA Meta-Analysis of Cytokines in Major Depression
Dowlati, Y., Herrmann, N., Swardfager, W., Liu, H., Sham, L., Reim, E. K., & Lanctôt, K. L. (2010) · Biological Psychiatry · doi:10.1016/j.biopsych.2009.09.033 · Cited by 4,729 · cited 1×
“Meta-analysis shows higher blood levels of pro-inflammatory cytokines in drug-free MDD patients, compared with healthy controls (Dowlati et al., 2010).”
BackgroundThe mouse brain in stereotaxic coordinates
Konsman, J.-P. (2003) · Psychoneuroendocrinology · doi:10.1016/s0306-4530(03)00088-x · Cited by 4,045 · cited 4×
“Microinjection needles were placed bilaterally into the NAc shell (+1.7 AP, ±0.75 ML, -3.6 DV) (Paxinos and Watson, 1998).”
MethodInfluentialInflammation and Its Discontents: The Role of Cytokines in the Pathophysiology of Major Depression
Miller, A. H., Maletic, V., & Raison, C. L. (2009) · Biological Psychiatry · doi:10.1016/j.biopsych.2008.11.029 · Cited by 3,848 · cited 1×
“Accumulating evidence suggests that inflammatory processes play a role in the pathophysiology of major depressive disorder (MDD; Dantzer et al., 2008; Hashimoto, 2009; Miller et al., 2009; Raison et al., 2010).”
BackgroundThe Neuroendocrinology of Stress: A Never Ending Story
Lightman, S. L. (2008) · Journal of Neuroendocrinology · doi:10.1111/j.1365-2826.2008.01711.x · Cited by 3,566
A Neurotrophic Model for Stress-Related Mood Disorders
Duman, R. S., & Monteggia, L. M. (2006) · Biological Psychiatry · doi:10.1016/j.biopsych.2006.02.013 · Cited by 3,375 · cited 3×
“…signaling to the pathophysiology of MDD, as well as the therapeutic mechanisms of antidepressants (Nestler et al., 2002; Hashimoto et al., 2004; Duman and Monteggia 2006; Martinowich et al., 2007; Hashimoto, 2010; Hashimoto, 2011, 2013a; Duman et al., 2012; Castrén, 2014; Lindholm and…”
BackgroundBardo, M. T., & Hammer, R. P. (1991) · Neuroscience · doi:10.1016/0306-4522(91)90226-e · Cited by 3,219
Cited by
Items 101–200 of 303
Sultana, T., Mannan, M. A., & Ahmed, T. (2018) · Clinical Phytoscience · doi:10.1186/s40816-018-0063-1 · Cited by 55
7,8-Dihydroxyflavone reverses the depressive symptoms in mouse chronic mild stress
Zhang, M.-W., Zhang, S.-F., Li, Z.-H., & Han, F. (2016) · Neuroscience Letters · doi:10.1016/j.neulet.2016.10.035 · Cited by 46
Regulation of actions and habits by ventral hippocampal trkB and adolescent corticosteroid exposure
Barfield, E. T., Gerber, K. J., Zimmermann, K. S., Ressler, K. J., Parsons, R. G., & Gourley, S. L. (2017) · PLoS Biology · doi:10.1371/journal.pbio.2003000 · Cited by 46
Tang, R., Cao, Q., Hu, S.-W., He, L., Du, P., Chen, G., Fu, R., Xiao, F., Sun, Y., Zhang, J., et al. (2021) · Acta Pharmacologica Sinica · doi:10.1038/s41401-021-00727-z · Cited by 46
Self-citationAytan, N., Choi, J., Carreras, I., Crabtree, L., Nguyen, B., Lehar, M., Blusztajn, J. K., Jenkins, B. G., & Dedeoglu, A. (2018) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2018.02.045 · Cited by 46
Yang, T., Massa, S. M., Tran, K. C., Simmons, D. A., Rajadas, J., Zeng, A. Y., Jang, T., Carsanaro, S., & Longo, F. M. (2016) · Neuropharmacology · doi:10.1016/j.neuropharm.2016.06.015 · Cited by 47
Qu, Y., Shan, J., Wang, S., Chang, L., Pu, Y., Wang, X., Tan, Y., Yamamoto, M. P., & Hashimoto, K. (2020) · European Archives of Psychiatry and Clinical Neuroscience · doi:10.1007/s00406-020-01208-w · Cited by 44
“The expressions of BDNF in the PFC of rodents with depression-like behaviors were lower than control rodents [26, 48, 50, 55].”
BackgroundSelf-citationRebai, R., Jasmin, L., & Boudah, A. (2021) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2021.111246 · Cited by 44
Nucleus accumbens in the pathogenesis of major depressive disorder: A brief review
Yajie, J., Zou, M., Wang, Y., & Wang, Y. (2023) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2023.03.004 · Cited by 43
“behavior tests (Garcia et al., 2008; Duman and Duman, 2005; Zhang et al., 2015), which underlines the regional differences of CREB function.”
Amin, N., Xie, S., Tan, X., Chen, Y., Ren, Q., Botchway, B. O. A., Hu, S., Ma, Y., Hu, Z., & Fang, M. (2020) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2020.109939 · Cited by 43
Self-citationPrefrontal cortical BDNF: A regulatory key in cocaine- and food-reinforced behaviors
Pitts, E. G., Taylor, J. R., & Gourley, S. L. (2016) · Neurobiology of Disease · doi:10.1016/j.nbd.2016.02.021 · Cited by 45
“…certain circumstances, the putative trkB agonist 7,8-DHF can induce dendritic spine proliferation in the hippocampus and oPFC (Zeng et al., 2012; Zhang et al., 2014a,b; Zimmermann et al., 2015), while cocaine decreases dendrite complexity and dendritic spine density in the oPFC (Gourley et al.,…”
BackgroundZhang, J.-C., Yao, W., Qu, Y., Nakamura, M., Dong, C., Yang, C., Ren, Q., Ma, M., Han, M., Shirayama, Y., et al. (2017) · Scientific Reports · doi:10.1038/s41598-017-07325-2 · Cited by 50
Self-citationJi, Y., Luo, J., Zeng, J., Fang, Y., Liu, R., Luan, F., & Zeng, N. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.643456 · Cited by 42
Val66Met polymorphism association with serum BDNF and inflammatory biomarkers in major depression
Caldieraro, M. A., McKee, M., Leistner-Segal, S., Vares, E. A., Kubaski, F., Spanemberg, L., Brusius-Facchin, A. C., Fleck, M. P., & Mischoulon, D. (2018) · The World Journal of Biological Psychiatry · doi:10.1080/15622975.2017.1347713 · Cited by 39
“Likewise, LPS-induced inflammation may cause depression-like behaviour by altering BDNF (Gibney et al. 2013; Zhang et al. 2015).”
BackgroundHashimoto, K. (2019) · Current Psychiatry Reports · doi:10.1007/s11920-019-1063-7 · Cited by 44
Self-citationDisruption of the NMDA receptor GluN2A subunit abolishes inflammation-induced depression
Francija, E., Petrovic, Z., Brkic, Z., Mitić, M., Radulović, J., & Adžić, M. (2018) · Behavioural Brain Research · doi:10.1016/j.bbr.2018.10.011 · Cited by 39
“This is in accordance with already published data indicating that LPS decreases BDNF in PFC and hippocampus (CA3, dentate gyrus) [28–30], which is considered to be important step in developing depressive-like behaviour [28,29,31].”
BDNF Signaling and Pain Modulation
Mazzitelli, M., Kiritoshi, T., Presto, P., Hurtado, Z., Antenucci, N., Ji, G., & Neugebauer, V. (2025) · Cells · doi:10.3390/cells14070476 · Cited by 42
“In mice, decreased levels of BDNF in the hippocampus and PFC were linked to depression-like behavior in an inflammation-induced mouse model of depression [229], and conditional knockout of BDNF in the forebrain attenuated the actions of the antidepressant desipramine [230].”
Roversi, K., Antoniazzi, C. T. D. D., Milanesi, L. H., Rosa, H. Z., Kronbauer, M., Rossato, D. R., Duarte, T., Duarte, M. M. M. F., & Bürger, M. E. (2019) · Molecular Neurobiology · doi:10.1007/s12035-019-1522-5 · Cited by 39
Glial mechanisms underlying major depressive disorder: Potential therapeutic opportunities
Rahman, S., & Alzarea, S. I. (2019) · Progress in molecular biology and translational science · doi:10.1016/bs.pmbts.2019.06.010 · Cited by 38
Ke, Y., Bu, S., Ma, H., Gao, L., Cai, Y., Zhang, Y., & Zhou, W. (2020) · Frontiers in Pharmacology · doi:10.3389/fphar.2019.01621 · Cited by 38
“BDNF and its receptor, tropomyosin-related kinase B (TrkB), are potential therapeutic targets for major depressive disorder (Zhang et al., 2014).”
BackgroundLuo, D., Shi, Y., Wang, J., Lin, Q., Sun, Y. E., Ye, K., Yan, Q., & Zhang, H. (2016) · Neuroscience Letters · doi:10.1016/j.neulet.2016.03.042 · Cited by 38
Fan, Y., Luan, X., Wang, X., Li, H., Zhao, H., Li, S., Li, X., & Qiu, Z. (2024) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2024.111143 · Cited by 37
“…among depressed mice induced by LPS, TrkB agonist 7,8-dihydroxyflavone (7, 8-DHF) significantly attenuated the reduction of TrkB and spine densities in the CA3 hippocampal region, dentate gyrus, and PFC (Zhang et al., 2014), thus promoting a rapid antidepressant effect (Zhang et al., 2016b).”
InfluentialSelf-citationLi, J., Luo, Y., Zhang, R., Shi, H., Zhu, W., & Shi, J. (2015) · International Journal of Molecular Sciences · doi:10.3390/ijms161226105 · Cited by 35
“Injector cannulae were removed 2 min after infusions [34,35,61].”
BackgroundHan, M., Zhang, J.-C., & Hashimoto, K. (2017) · Clinical Psychopharmacology and Neuroscience · doi:10.9758/cpn.2017.15.1.64 · Cited by 36
Self-citationRosas-Sánchez, G. U., Germán-Ponciano, L. J., Guillén-Ruiz, G., Cueto‐Escobedo, J., Limón-Vázquez, A. K., Rodríguez‐Landa, J. F., & Soria-Fregozo, C. (2024) · Biomedicines · doi:10.3390/biomedicines12122744 · Cited by 43
“…favoring the binding of this neurotrophins to its receptor TrkB, thereby activating several intracellular signaling pathways such as MAPK/ERK and PI3K, which are essential for promoting plastic changes in the brain and maintaining neuronal survival under stress conditions [171]. conditions [171].”
Ago, Y., Hasebe, S., Nishiyama, S., Oka, S., Onaka, Y., Hashimoto, H., Takuma, K., & Matsuda, T. (2015) · The International Journal of Neuropsychopharmacology · doi:10.1093/ijnp/pyv062 · Cited by 37
“5 mg/kg), and behaviors were analyzed 24 h after the injection (Zhang et al., 2015).”
Sohroforouzani, A. M., Shakerian, S., Ghanbarzadeh, M., & Alaei, H. (2021) · Behavioural Brain Research · doi:10.1016/j.bbr.2021.113645 · Cited by 34
Fang, X., Yang, C., Li, S., Zhan, G., Zhang, J., Huang, N., Du, X., Xu, H., Hashimoto, K., & Luo, A. (2018) · European Archives of Psychiatry and Clinical Neuroscience · doi:10.1007/s00406-018-0909-z · Cited by 34
“Furthermore, we examined if 7,8-dihydroxyflavone (7,8-DHF; a TrkB agonist) [20, 26, 34] or ANA-12 (a TrkB antagonist) [20, 26, 35, 36] could improve anhedonia-like symptoms and alterations in BDNF-TrkB signaling in anhedonia-susceptible rats after SNI.”
BackgroundSelf-citationWang, Y. Y., Jiang, R., Wu, Z., Zhou, L., Xu, J., Huang, C., Yang, L., Zhu, B., Yan, E., Liu, C., et al. (2021) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2021.173226 · Cited by 37
Self-citationAno, Y., Kita, M., Kitaoka, S., & Furuyashiki, T. (2019) · Nutrients · doi:10.3390/nu11092161 · Cited by 33
“In contrast, inflammation suppression can ameliorate these impairments [38,39].”
BackgroundZhan, G., Huang, N., Li, S., Hua, D., Zhang, J., Fang, X., Yang, N., Luo, A., & Yang, C. (2018) · Psychopharmacology · doi:10.1007/s00213-018-5041-2 · Cited by 32
Self-citationWhat Are the Causes for Discrepancies of Antidepressant Actions of (2R,6R)-Hydroxynorketamine?
Hashimoto, K., & Shirayama, Y. (2017) · Biological Psychiatry · doi:10.1016/j.biopsych.2017.12.007 · Cited by 32
Self-citationSoluble epoxide hydrolase: a new therapeutic target for depression
Hashimoto, K. (2016) · Expert Opinion on Therapeutic Targets · doi:10.1080/14728222.2016.1226284 · Cited by 32
Self-citationAzogu, I., & Plamondon, H. (2017) · Neuropharmacology · doi:10.1016/j.neuropharm.2017.07.008 · Cited by 32
Design, Synthesis and Evaluation of Oxazaborine Inhibitors of the NLRP3 Inflammasome
Baldwin, A. G., Tapia, V. S., Swanton, T., White, C., Beswick, J. A., Brough, D., & Freeman, S. (2018) · ChemMedChem · doi:10.1002/cmdc.201700731 · Cited by 32
Wei, Y., Chang, L., & Hashimoto, K. (2021) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2021.04.010 · Cited by 30
Self-citationYao, W., Zhang, J., Ishima, T., Ren, Q., Yang, C., Dong, C., Ma, M., Saito, A., Honda, T., & Hashimoto, K. (2016) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2016.10.037 · Cited by 31
Self-citationXiong, Z., Zhang, K., Ishima, T., Ren, Q., Chang, L., Chen, J., & Hashimoto, K. (2018) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2018.10.005 · Cited by 29
Self-citationBohm-Levine, N., Goldberg, A., Mariani, M. M., Frankfurt, M., & Thornton, J. E. (2019) · Hormones and Behavior · doi:10.1016/j.yhbeh.2019.104590 · Cited by 31
Germán-Ponciano, L. J., Rosas-Sánchez, G. U., Cueto‐Escobedo, J., Fernández-Demeneghi, R., Guillén-Ruiz, G., Soria-Fregozo, C., Herrera-Huerta, E. V., & Rodríguez‐Landa, J. F. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms231810896 · Cited by 31
“This could be useful on the design of pharmacological prototypes based on the structure of flavonoids with the aim of exerting rapid antidepressant effects, since the use of TrkB modulators has been shown to shorten latency to the appearance of therapeutic effects [87,203].”
BackgroundSriram, C. S., Jangra, A., Gurjar, S. S., Hussain, M. I., Borah, P., Lahkar, M., Mohan, P., & Bezbaruah, B. K. (2015) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2015.03.022 · Cited by 31
Ren, Q. (2019) · Frontiers in Pharmacology · doi:10.3389/fphar.2019.00420 · Cited by 31
“As such, TPPU could produce antidepressant effects in inflammation model of depression because standard antidepressants, such as selective serotonin reuptake inhibitors and serotonin norepinephrine reuptake inhibitors, do not demonstrate therapeutic effects in such models (Zhang et al., 2015).”
BackgroundSelf-citationOrío, L., Alén, F., Ballesta, A., Martin, R., & de Heras, R. G. (2020) · Molecules · doi:10.3390/molecules25143207 · Cited by 30
“The Forced Swim Test and the Sucrose Preference Test were employed to assess any depressive-like behavioral responses, being some of the most commonly used tests to assess this kind of behavior in animal models [83,84].”
MethodEnhanced pro-BDNF-p75NTR pathway activity in denervated skeletal muscle
Aby, K., Antony, R. M., Eichholz, M., Srinivasan, R., & Li, Y. (2021) · Life Sciences · doi:10.1016/j.lfs.2021.120067 · Cited by 30
Wei, Y., Chang, L., Liu, G., Wang, X., Yang, Y. H., & Hashimoto, K. (2022) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2022.109098 · Cited by 30
Self-citationChang, H., Wang, Y.-H., Tung, C., Yeh, C., & Liu, Y. (2016) · Psychiatry Investigation · doi:10.4306/pi.2016.13.5.531 · Cited by 31
miR-34a induces spine damages via inhibiting synaptotagmin-1 in depression
Yi, L.-T., Zhu, J.-X., Dong, S.-Q., Li, C.-F., Zhang, Q.-P., Cheng, J., & Liu, Q. (2020) · Neurobiology of Stress · doi:10.1016/j.ynstr.2020.100243 · Cited by 26
Rosas-Sánchez, G. U., German-Ponciano, L. J., Guillén-Ruiz, G., Cueto-Escobedo, J., Limón-Vázquez, A. K., Rodríguez-Landa, J. F., & Soria-Fregozo, C. (2024) · doi:10.20944/preprints202410.2591.v1 · Cited by 28
Liang, W., Liu, Y., Zhou, K., Jian, P., Zhang, Q., Chang, Z., Wu, L., Hong-sheng, C., & Zhang, L. (2021) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2021.114655 · Cited by 27
Fukuchi, M., Okuno, Y., Nakayama, H., Nakano, A., Mori, H., Mitazaki, S., Nakano, Y., Toume, K., Jo, M., Takasaki, I., et al. (2019) · Scientific Reports · doi:10.1038/s41598-019-48361-4 · Cited by 27
Ren, C., Li, L.-X., Dong, A.-Q., Zhang, Y., Hu, H., Mao, C., Wang, F., & Liu, C. (2021) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.1c00095 · Cited by 28
Camargo, A., Dalmagro, A. P., Wolin, I. A. V., Kaster, M. P., & Rodrigues, A. L. S. (2021) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2021.09.057 · Cited by 26
Deletion of serine racemase confers D-serine –dependent resilience to chronic social defeat stress
Dong, C., Zhang, J., Ren, Q., Ma, M., Qu, Y., Zhang, K., Yao, W., Ishima, T., Mori, H., & Hashimoto, K. (2018) · Neurochemistry International · doi:10.1016/j.neuint.2018.03.008 · Cited by 27
Self-citationHossen, S. M. M., Tanim, M. A. H., Hossain, M. S., Sami, S. A., & Emon, N. U. (2021) · Saudi Journal of Biological Sciences · doi:10.1016/j.sjbs.2021.07.016 · Cited by 25
Lin, J., Fang, S., Tang, S., Hu, M. Y., Long, Y., Ghosh, A., Sun, H., Kong, L., & Hong, H. (2017) · Acta Pharmacologica Sinica · doi:10.1038/aps.2016.145 · Cited by 28
Chang, L., Toki, H., Qu, Y., Fujita, Y., Mizuno-Yasuhira, A., Yamaguchi, J.-I., Chaki, S., & Hashimoto, K. (2018) · International Journal of Neuropsychopharmacology · doi:10.1093/ijnp/pyy053 · Cited by 25
Self-citationColla, A. R. D. S., Pazini, F. L., Lieberknecht, V., Camargo, A., & Rodrigues, A. L. S. (2021) · Metabolic Brain Disease · doi:10.1007/s11011-020-00658-4 · Cited by 25
Dal‐Pizzol, F., de Medeiros, G. F., Michels, M., Mazeraud, A., Bozza, F. A., Ritter, C., & Sharshar, T. (2021) · Neurotherapeutics · doi:10.1007/s13311-020-00981-9 · Cited by 26
Sotoyama, H., Namba, H., Tohmi, M., & Nawa, H. (2023) · Biomolecules · doi:10.3390/biom13020372 · Cited by 26
Matured Hop Bitter Acids in Beer Improve Lipopolysaccharide-Induced Depression-Like Behavior
Fukuda, T., Ohya, R., Kobayashi, K., & Ano, Y. (2019) · Frontiers in Neuroscience · doi:10.3389/fnins.2019.00041 · Cited by 26
Zemdegs, J., Rainer, Q., Grossmann, C. P., Rousseau-Ralliard, D., Grynberg, A., Ribeiro, E., & Guiard, B. P. (2018) · Frontiers in Neuroscience · doi:10.3389/fnins.2018.00974 · Cited by 23
“, spine density) in the mouse hippocampus (Zhang et al., 2014).”
BackgroundLiu, H., Jiang, J., & Zhao, L. (2019) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2019.08.032 · Cited by 23
Wu, X., Liu, C., Wang, J., Guan, Y., Song, L., Chen, R., & Gong, M. (2022) · Neurochemical Research · doi:10.1007/s11064-022-03641-w · Cited by 24
“ZnPP was dissolved in physiological saline to a final concentration of 1% dimethyl sulfoxide [55].”
MethodXu, Y., Zhang, J., Yu, L., Zhang, W., Zhang, Y., Shi, Y., Zhang, S., Li, C., & Tian, J. (2023) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.17975 · Cited by 23
“8,9 Furthermore, stress-induced negative cellular functional and morphological alterations in the pre-frontal cortex (PFC) are consistent with the levels of essential receptors and proteins associated with synaptic plasticity.”
BackgroundSelf-citationLu, L., Yang, L.-K., Yue, J., Wang, X., Qi, J., Yang, F., Feng, B., & Liu, S. (2021) · Neuroscience Letters · doi:10.1016/j.neulet.2021.136284 · Cited by 22
Tan, Y., Fujita, Y., Pu, Y., Chang, L., Qu, Y., Wang, X., & Hashimoto, K. (2022) · European Archives of Psychiatry and Clinical Neuroscience · doi:10.1007/s00406-021-01365-6 · Cited by 22
“, Columbia, MD) was used as reported previously [23, 54, 56, 57].”
MethodSelf-citationde la Tremblaye, P. B., Linares, N. F. N., Schock, S., & Plamondon, H. (2016) · Experimental Neurology · doi:10.1016/j.expneurol.2016.07.019 · Cited by 25
Liu, Y., Ma, C., Li, H., Shen, H., Li, X., Fu, X., Wu, J., & Chen, G. (2019) · Journal of Molecular Neuroscience · doi:10.1007/s12031-019-01365-1 · Cited by 22
Self-citationVakhitova, Y. V., Kalinina, T. S., Zainullina, L. F., Lusta, A. Y., Volkova, A. V., Kudryashov, N. V., Gudasheva, T. A., Shimshirt, A. A., Kadnikov, I. A., Voronin, M. V., et al. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms222413381 · Cited by 21
“The antidepressant properties of 7,8-dihydroxyflavone and ANA-12 as well as their ability to increase BDNF and pTrkB-Tyr706/707 levels have also been demonstrated in a social defeat stress model and LPS-stimulated depressive-like behavior [81,82].”
BackgroundWan, X., Eguchi, A., Qu, Y., Yang, Y., Chang, L., Shan, J., Mori, C., & Hashimoto, K. (2022) · European Archives of Psychiatry and Clinical Neuroscience · doi:10.1007/s00406-022-01437-1 · Cited by 21
Self-citationThe protective role of ginsenoside Rg3 in heart diseases and mental disorders
Shi, L., Luo, J., Wei, X., Xu, X., & Tu, L. (2024) · Frontiers in Pharmacology · doi:10.3389/fphar.2024.1327033 · Cited by 21
Giacobbe, J., Pariante, C. M., & Borsini, A. (2020) · Journal of Psychopharmacology · doi:10.1177/0269881120936538 · Cited by 23
“…ECT increases levels of blood brainderived neurotrophic factor (BDNF) (Brunoni et al., 2014), a factor relevant to cellular plasticity which triggers signalling cascades regulating the transcription of neuronal survival and growth factors (Björkholm and Monteggia, 2016; Zhang et al., 2014).”
BackgroundRosso, P., Nicolò, S. D., Carito, V., Fiore, M., Iannitelli, A., Moreno, S., & Tirassa, P. (2017) · CNS Neuroscience & Therapeutics · doi:10.1111/cns.12661 · Cited by 24
“The evidence that inhibition of proBDNF [32] or infusion of TrkB agonists [33,34] might reverse the neurodegenerative process in animal models further supports the concept that an unbalance between BDNF maturation and TrkB/p75NTR expression is trigger event of apoptosis in the brain.”
ResultCamargo, A., Dalmagro, A. P., Fraga, D. B., Rosa, J. M., Zeni, A. L. B., Kaster, M. P., & Rodrigues, A. L. S. (2021) · Psychopharmacology · doi:10.1007/s00213-021-05879-8 · Cited by 23
Marrero‐Cristobal, G., Gelpi‐Dominguez, U., Silva, R. J. M., Alvarado-Torres, J. K., Perez‐Torres, J., Perez‐Perez, Y., & Sepulveda-Orengo, M. T. (2021) · Journal of Neuroscience Research · doi:10.1002/jnr.24990 · Cited by 23
Madjid, N., Lidell, V., Nordvall, G., Lindskog, M., Ögren, S.-O., Forsell, P., & Sandin, J. (2023) · Psychopharmacology · doi:10.1007/s00213-023-06410-x · Cited by 19
Avolio, E., Fazzari, G., Mele, M., Alò, R., Zizza, M., Jiao, W., Vito, A. D., Barni, T., Mandalà, M., & Canonaco, M. (2016) · Molecular Neurobiology · doi:10.1007/s12035-016-0171-1 · Cited by 21
Rui, T., Wang, Z., Li, Q., Wang, H., Wang, T., Zhang, M., Tao, L., & Luo, C. (2019) · Neurochemistry International · doi:10.1016/j.neuint.2019.104606 · Cited by 20
Hashimoto, K. (2016) · European Archives of Psychiatry and Clinical Neuroscience · doi:10.1007/s00406-016-0682-9 · Cited by 20
Self-citationLim, S. Y., & Cengiz, P. (2022) · Neuropharmacology · doi:10.1016/j.neuropharm.2022.109260 · Cited by 22
Wakasugi, D., Kondo, S., Ferdousi, F., Mizuno, S., Yada, A., Tominaga, K., Takahashi, S., & Isoda, H. (2024) · Cell Communication and Signaling · doi:10.1186/s12964-024-01691-x · Cited by 19
“The neurotrophic activity of BDNF/ TrkB is believed to modulate the intricate interaction between neuroinflammation and neurogenesis in the pathogenesis of depression-like disorders [8, 32–34], making it a promising therapeutic target for such conditions.”
BackgroundAntidepressant effect in diabetes-associated depression: A novel potential of RAAS inhibition
Balogh, D. B., Molnár, Á., Hosszú, Á., Lakat, T., Hodrea, J., Szabo, A. J., Lénárt, L., & Fekete, A. (2020) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2020.104705 · Cited by 22
Wang, H., Chen, Y., Zhao, A., Shen, Z., & Zhang, Y. (2026) · Frontiers in Pharmacology · doi:10.3389/fphar.2025.1709060 · Cited by 21
He, L., Mo, X., He, L., Ma, Q., Cai, L., Zheng, Y., Huang, L., Lin, X., Wu, M.-S., Ding, W., et al. (2023) · Phytomedicine · doi:10.1016/j.phymed.2023.155332 · Cited by 20
Self-citationBarfield, E. T., & Gourley, S. L. (2017) · Frontiers in Behavioral Neuroscience · doi:10.3389/fnbeh.2017.00237 · Cited by 18
“Male and female mice were administered (i.p.) the putative trkB agonist, 7,8-dihydroxyflavone (7,8-DHF; Sigma; 3 mg/kg; dissolved in 17% DMSO and saline; Zhang et al., 2014), or vehicle daily from P39 to 47, overlapping with the end of the adolescent CORT exposure period.”
BackgroundLv, D., Chen, Y., Shen, M., Liu, X., Zhang, Y., Xu, J., & Wang, C. (2018) · Neuropharmacology · doi:10.1016/j.neuropharm.2018.09.046 · Cited by 19
Maciak, K., Dziedzic, A., & Saluk, J. (2022) · The FASEB Journal · doi:10.1096/fj.202201348r · Cited by 22
The p75 neurotrophin receptor might mediate sepsis-induced synaptic and cognitive impairments
Ji, M., Yuan, H., Yuan, S., Xia, J., & Yang, J. (2018) · Behavioural Brain Research · doi:10.1016/j.bbr.2018.03.042 · Cited by 19
Receptor tyrosine kinases (RTKs)
Batool, Z., Azfal, A., Liaquat, L., Sadir, S., Nisar, R., Inamullah, A., Ghalib, A. U. F., & Haider, S. (2023) · Elsevier eBooks · doi:10.1016/b978-0-443-18677-6.00012-9 · Cited by 23
Fukuda, M., Takatori, A., Nakamura, Y., Suganami, A., Hoshino, T., Tamura, Y., & Nakagawara, A. (2016) · Neurochemistry International · doi:10.1016/j.neuint.2016.04.017 · Cited by 19
Pytka, K., Młyniec, K., Podkowa, K., Podkowa, A., Jakubczyk, M., Żmudzka, E., Lustyk, K., Sapa, J., & Filipek, B. (2017) · Pharmacological Reports · doi:10.1016/j.pharep.2017.01.026 · Cited by 19
Sharma, G. P., Frei, A. C., Narayanan, J., Gasperetti, T., Veley, D., Amjad, A., Albano, K., Fish, B. L., & Himburg, H. A. (2021) · PLoS ONE · doi:10.1371/journal.pone.0259042 · Cited by 17
Guo, J., Fang, M., Xiong, Z., Zhou, K., & Zeng, P. H. (2023) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s00210-023-02628-w · Cited by 17
“LPS, a bacterial endotoxin, is widely used to establish animal models of depression related to inflammation (Dantzer 2001; Ohgi et al. 2013; Ma et al. 2014; Zhang et al. 2014; Yao et al. 2015).”
Rapid Antidepressant Activity of Ketamine Beyond NMDA Receptor
Hashimoto, K. (2017) · Springer eBooks · doi:10.1007/978-3-319-49795-2_4 · Cited by 17
Self-citationXiong, Z., Zhang, K., Ishima, T., Ren, Q., Ma, M., Pu, Y., Chang, L., Chen, J., & Hashimoto, K. (2018) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2018.11.010 · Cited by 17
Self-citationThe role of soluble epoxide hydrolase and its inhibitors in depression
Borsini, A. (2021) · Brain Behavior & Immunity - Health · doi:10.1016/j.bbih.2021.100325 · Cited by 16
“As such, TPPU is likely to be more effective than treatment with selective serotonin reuptake inhibitors and serotonin norepinephrine reuptake inhibitors, which do not show therapeutic effects in the same LPS-induced model of depression (Zhang et al., 2014).”
The potential combinational effect of miR-34a with celecoxib in osteosarcoma
Chen, X., Peng, D., Shen, Y., Liu, B., Zhou, H., Tao, H., & Huang, J. (2017) · Anti-Cancer Drugs · doi:10.1097/cad.0000000000000530 · Cited by 17
Abdelaziz, M. M., Mohamed, A. F., Zaki, H. F., & Gad, S. S. (2023) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s00210-023-02717-w · Cited by 16
“It has previously been demonstrated that ERK activation is necessary for BDNF-related improvements in learning and long-term potentiation (Peng et al. 2010; Zhang et al. 2015a).”
BackgroundSun, S., Zhao, J.-N., Bi, P.-W., Zhang, H., Li, G.-X., Yan, J., Li, Y., Yin, Y., & Cheng, H. (2025) · Metabolic Brain Disease · doi:10.1007/s11011-025-01583-0 · Cited by 15
Skiteva, O., Yao, N., & Chergui, K. (2021) · Translational Psychiatry · doi:10.1038/s41398-021-01658-3 · Cited by 13
Metadata
- Authors
- Zhang, J.-C., Wu, J., Fujita, Y., Yao, W., Ren, Q., Yang, C., Li, S.-X., Shirayama, Y., & Hashimoto, K.
- Affiliations
- Chiba University (JP)
- Corresponding author
- Hashimoto, Kenji
- Venue
- International Journal of Neuropsychopharmacology
- Publisher
- Oxford University Press (OUP)
- Published
- 2015-01-26
- Volume
- 18
- Issue
- 4
- ISSN
- 1461-1457 (ISSN-L)
- 1469-5111
- PMC
- PMC4360225
- OpenAlex
- W2055018912
- Cited by
- 289
- References
- 72
- Citations by year
- 2026: 6 · 2025: 14 · 2024: 18 · 2023: 23 · 2022: 26 · 2021: 46 · 2020: 17 · 2019: 24 · 2018: 33 · 2017: 25 · 2016: 37 · 2015: 18
- FWCI
- 27.18
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- cc-by
- Locations
- The International Journal of Neuropsychopharmacology (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- HighWire Press Open Archive (submittedVersion)
- Funders
- Eli Lilly and Company
- Ministry of Education, Culture, Sports, Science and Technology (24116006)
- Astellas Pharma
- Chiba University
- SENSHIN Medical Research Foundation
- Japan Society for the Promotion of Science (24116006)
- Topics
- Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
- Life Sciences › Neuroscience › Biological Psychiatry › Tryptophan and brain disorders
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Nerve injury and regeneration
- Keywords
- TrkB signaling, brain-derived neurotrophic factor, antidepressant effects, depression-like behavior, lipopolysaccharide-induced inflammation, 7,8-dihydroxyflavone, ANA-12, dendritic spine density, hippocampus, prefrontal cortex, nucleus accumbens, hypothalamic-pituitary-adrenal axis, major depressive disorder
- MeSH terms
- Mechanistic Target of Rapamycin Complex 1, Animals, Antidepressive Agents, Azepines, Benzamides, Depressive Disorder, Disease Models, Animal, Hippocampus, Lipopolysaccharides, Male, Mice, Inbred C57BL, Nucleus Accumbens, Phosphorylation, Prefrontal Cortex, Brain-Derived Neurotrophic Factor, Receptor, trkB, Multiprotein Complexes, Flavones, Dendritic Spines, TOR Serine-Threonine Kinases
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.